Back to Search
Start Over
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- Source :
- Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-1 (2022)
- Publication Year :
- 2022
- Publisher :
- BMC, 2022.
Details
- Language :
- English
- ISSN :
- 17589193
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Alzheimer’s Research & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9e3c60d518ed4e89a11178d614b7e937
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13195-022-00995-9